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Abstract
Background: Lung cancer is one of the leading causes of cancer related deaths worldwide. Marine microalgae are
a source of biologically active compounds and are widely consumed as a nutritional supplement in East Asian
countries. It
has been reported that Chlorella or Chlorella extracts have various beneficial pharmacological compounds that
modulate immune responses; however, no studies have investigated the anti-cancer effects of Chlorella sorokiniana
(CS) on non-small cell lung cancer (NSCLC).
Methods: In this study, we evaluated the anti-cancer effects of CS in two human NSCLC cell lines (A549 and CL1-5
human lung adenocarcinoma cells), and its effects on tumor growth in a subcutaneous xenograft tumor model. We
also investigated the possible molecular mechanisms governing the pharmacological function of CS.
Results: Our results showed that exposure of the two cell lines to CS resulted in a concentration-dependent
reduction in cell viability. In addition, the percentage of apoptotic cells increased in a dose-dependent manner,
suggesting that CS might induce apoptosis in human NSCLC cells. Western blot analysis revealed that exposure to
CS resulted in increased protein expression of the cleaved/activated forms of caspase-3, caspase-9, and PARP,
except caspase-8. ZDEVD (caspase-3 inhibitor) and Z-LEHD (caspase-9 inhibitor) were sufficient at preventing
apoptosis in both A549 and CL1-5 cells, proving that CS induced cell death via the mitochondria-mediated
apoptotic pathway. Exposure of A549 and CL1-5 cells to CS for 24 h resulted in decreased expression of Bcl-2
protein and increased expression of Bax protein as well as decreased expression of two IAP family proteins, survivin
and XIAP.
Conclusions: We demonstrated that CS induces mitochondrial-mediated apoptosis in NSCLC cells via
downregulation of Bcl-2, XIAP and survivin. In addition, we also found that the tumors growth of subcutaneous
xenograft in vivo was markedly inhibited after oral intake of CS.
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Background
Lung cancer is one of the leading causes of cancer related
deaths worldwide. In 2012, an estimated 1.8 million new
cases of lung cancer were diagnosed, accounting for
approximately 13% of all cancer diagnoses [1]. Non–small
cell lung cancer (NSCLC) is the most common type of
lung cancer and the 5-year survival rate for patients
with this disease is about 22% [2]. Current treatments
for NSCLC such as surgery, chemotherapy and
radiotherapy are not sufficient and the outcomes of
treatment remain poor because of drug resistance and
toxicity.
Marine microalgae contain several groups of biologic-
ally active compounds including proteins, minerals,
vitamins, fatty acids, and antioxidants [3]. Chlorella is a
unicellular green microalgae and is widely consumed as
a nutritional supplement in East Asian countries. Chlor-
ella or Chlorella extracts have been demonstrated to
modulate immune response [4, 5], decrease hepatitis C
virus viral load [6], and to have anti-cancer effects in hu-
man prostate cancer cell lines [7], human lung cancer
cells [8], liver cancer cells [9], and human colon cancer
cells [10]. However, the underlying molecular mecha-
nisms governing the antitumor activity of Chlorella
remain unclear.
Chlorella sorokiniana (CS), a species of green algae of
the genus chlorella, has been demonstrated to be effective
at inducing immune responses [4]; however, no studies
have investigated the anti-cancer effects of CS in NSCLC
cells. In this study, we evaluated the anti-cancer effects of
CS in two NSCLC cell lines, namely A549 and CL1-5
human lung adenocarcinoma cells, and its effects on
tumor growth in a subcutaneous xenograft tumor model.
We also investigated the possible molecular mechanisms
governing the pharmacologic function of CS.
Methods
Cell culture and reagents
The human lung adenocarcinoma cell lines A549 and
CL1-5 were cultured in Dulbecco’s modified eagle
medium (DMEM, Invitrogen, Rockville, MD) supple-
mented with 10% fetal bovine serum (FBS, Gibco,
Grand Island, NY) and 100 U/ml of penicillin (Gibco,
Grand Island, NY) and 100 mg/ml of streptomycin
(Gibco, Grand Island, NY). Cultures were maintained
at 37 °C in a humidified incubator in an atmosphere
of 5% CO2.
Chlorella sorokiniana extract (CSE)
Chlorella sorokiniana, single-cell thermophilic green
algae, was provided by International Cryptomonadales
Biotechnology (Taiwan). The Chlorella sorokiniana pow-
ders were refluxed with distilled water for 1 h. The
extract was filtered by N0.5 filter paper (Tokyo, japan)
and vacuum concentrated at 60 °C until the solid content
of liquid extract was 5%.
Cell viability assay
The cytotoxic effects of CS cellular viability were assessed
using the 3-(4,5-dimethylthiazol-2-y1) -2,5-diphenyltetra-
thallium bromide (MTT) assay (Sigma-Aldrich, St. Louis,
MO). Cells were plated in 24-well plates for 24 h, after
which various concentrations of CS (0–1000 ng/ml) were
added and incubated for 24 h. After removing the medium
and adding 200 μL of 1 ×MTT solution to each well and
allowed to incubate for 4 h. The resulting formazan
crystals were then dissolved by adding 600 μL DMSO.
The spectrophotometric absorbance was measured at
570 nm in a microplate reader (TECAN, Durham, NC).
Cell lysis and western blot analysis
Whole cell protein was lysed in 2% SDS comprising
10 mM EDTA, 50 mM Tris base, 10% SDS pH 8.0 and
boiled at 95 °C for 10 min. Protein concentrations were
assessed using a BCA protein assay kit (Pierce, Rockford,
IL). Equal amounts of protein were loaded on 10–15%
SDS PAGE gels, transferred to polyvinylidene difluoride
(PVDF, GE Healthcare, Freiburg, Germany) membranes
and blocked with 5% nonfat milk in TBST buffer
(20 mM Tris-HCl,120mMNaCl, 0.1% Tween 20) for 1 h.
Membranes were incubated with various primary anti-
bodies against cleaved caspase-3, cleaved caspase-9,
cleaved-8, cleaved-PARP, Bcl-2, Bax, XIAP, survivn, cyto-
chorome c, COX-IV, and β-actin (all from cell signaling,
Danvers, MA) at 4 °C overnight. After washing, the blots
were incubated with HRP-labeled secondary antibodies
(cell signaling, Danvers, MA) for 2 h. The signals on the
blots were then developed using the enhanced chemilu-
minescence system (ECL, Perkin Elmer, Waltham, MA)
and analyzed with the Hansor Luminescence Image
system (Taichung, Taiwan).
Mitochondria/Cytosol fractionation
The mitochondrial fraction from the cytosolic fraction of
A549 and CL1-5 cells was isolated using a mitochondria/
cytosol fractionation kit (Biovision, Mountain View, CA).
Cells were harvested by trypsinization and washed twice
with cold PBS. Then, all cells resuspended in 500 μL of
cytosol extraction buffer and maintained on ice for
10 min. Cells were homogenized on ice for 30 to 50 passes
using a Dounce tissue grinder (Biovision, Mountain View,
CA) and centrifuged at 3000 rpm for 10 min at 4 °C. The
supernatants were collected and centrifuged again at
13,000 rpm for 30 min at 4 °C.
Cell cycle analysis and sub-G1 measurement
Cells (3 × 105 cells/dish) were plated on 6-cm dishes
for 24 h. The cells were then treated with various
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concentrations of CS for different of time intervals
and then collected by centrifugation. The pellets were
fixed with 75% ethanol at −20 °C overnight. Cells
were then centrifuged and resuspended in 500 μL of
PI staining solution comprising 2 mg/mL RNase,
1 mg/mL PI and 5% Triton X-100 maintained at 37 °C for
30 min in the dark. The cells were then analyzed using
Accuri 5 flow cytometry (BD Biosciences, San Jose, CA).
The percentages of cells distribution of the cell cycle in
different phases (sub-G1, G0/G1, S, and G2/M) were cal-
culated using C6 Accuri system software (BD Biosciences,
San Jose, CA).
Annexin V assay
Apoptosis assay was measured using a BioVision annexin
V-FITC apoptosis detection kit (BioVision, Mountain
View, CA). A549 and CL1-5 cells were implanted onto 6-
cm dishes for 24 h and then treated with different doses of
CS for 12 h. Cells were harvested by trypsinization and
then resuspended in 100 μL of binding buffer. Cell sus-
pensions were incubated with 1 μL of annexinV-FITC and
1 μL of propidium iodide (PI) for 10 min at room
temperature in the dark. The cells were assessed immedi-
ately by Accuri 5 flow cytometry (BD Biosciences, San
Jose, CA). The percentage of apoptotic cells (annexin v+)
was calculated with C6 Accuri system software (BD
Biosciences, San Jose, CA).
Mitochondrial membrane potential assay
The mitochondria-specific cationic dye JC-1 (Invitrogen,
Carlsbad, CA), which undergoes potential-dependent ac-
cumulation in mitochondria, was used to measure mem-
brane potential. When the membrane potential (ΔΨ) is
below 120 mV, JC-1 is monomeric and emits green light
(540 nm) following excitation with blue light (490 nm).
At membrane potentials higher than 120 mV, JC-1
monomer aggregates and emits red light (590 nm)
following excitation with green light (540 nm). For the
assay, cells were seeded onto 96-well plates and treated
with various concentrations of CS for 24 h, followed by
staining with 10 μg/ml JC-1 for 30 min at 37 °C. The
samples were analyzed immediately using Accuri 5 flow
cytometry (BD Biosciences, San Jose, CA). The data
were analyzed using C6 Accuri system software (BD
Biosciences, San Jose, CA) and displayed in a dot plot of
JC-1 red fluorescence (Y-axis) against JC-1 green fluor-
escence (X-axis).
In vivo antitumor activity
In total, 1 × 107 CL1-5 cells were subcutaneously
injected into the right flank of 16-week-old female
BALB/c nu/nu mice. Tumor-bearing mice were subdi-
vided into groups of five mice. Therapy was initiated
10 days after tumor inoculation when the mean tumor
volume was 50 mm3. CS was dissolved in ddH2O and
mice were fed a daily dose of 50 mg CS/kg body weight.
Control mice were fed orally with 100 μL of water.
Tumor volumes were calculated as (width)2 x length/2
and expressed in mm3.
Statistical analysis
Statistical analyses were performed by using GraphPad
Prism software, version 4.0 (GraphPad Software, Inc., La
Jolla, CA, USA). Results are expressed as mean ± standard
deviation. Statistical analyses were performed by one-way
ANOVA followed by Tukey’s post-hoc test. The differ-
ences between two groups were compared using the
Student’s t test. A P-value <0.05 was considered to repre-
sent statistical significance.
Results
Cytotoxic and cell viability effects of CS in A549 and
CL1-5 cells
To determine the cytotoxic effects of CS on cells, A549
and CL1-5 cells were treated with 15.625 to 1000 ng/ml
CS for 24 h and then cell viability was determined using
the MTT assay. As shown in Fig. 1, exposure of the two
cell lines to CS resulted in a concentration-dependent
reduction in cell viability.
CS induces apoptosis in A549 and CL1-5 cells
To examine whether CS causes cell growth inhibition by
inducing cell-cycle arrest or apoptosis, A549 and CL1-5
cells were assayed using PI staining and subjected to
flow cytometric analysis. The results are presented in
Fig. 2a. No cell cycle arrest was noted after 24 h of
exposure to CS; however, there was a significant dose-
dependent increase in the number of cells in the sub-G1
Fig. 1 Effects of Chlorella sorokiniana (CS) on viability of A549 and
CL1-5 cells. Cells were treated with the indicated concentrations of
CS for 24 h following attachment. Cell viability was assessed by the
MTT assay. The viability of untreated cells (control) was considered
100%. Each point on the graph represents the mean ± SD of triplicate
wells. The data presented are representatives of three independent
experiments with similar results. ***P value <0.001 compared with the
control group
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phase, which is typically considered to indicate apop-
tosis. To further determine whether CS induced apop-
tosis, we used flow cytometry after staining with annexin
V-FITC and propidium iodide (PI). As shown in Fig. 2b,
the percentage of apoptotic cells (annexin-V+/PI- and
annexin V+/PI+) increased in a dose-dependent manner,
suggesting that CS might induce apoptotic cell death in
human NSCLC cells.
CS induces caspase-dependent cell death in A549 and
CL1-5 cells
Chemotherapeutic agents can elicit cell death via one
of two apoptotic signal transduction pathways, namely
an intrinsic (mitochondria-mediated) or extrinsic pathway.
These pathways converge at several downstream points,
including caspase-3, and/or caspase-7. Activated caspase-
3 and/or caspase-7 cleave poly (ADP-ribose) polymerase
(PARP), which eventually leads to apoptosis [11]. Thus, in
order to clarify the type of a CS-induced apoptotic path-
way, the cleaved forms of caspase-8, caspase-9, caspase-3
and PARP were measured by Western blotting. As pre-
sented in Fig. 3a, the protein expression of the cleaved/ac-
tivated forms of caspase-9, caspase-3, and PARP, but not
caspase-8, were increased in both cell lines after exposure
to CS for 24 h. Activation of caspase-9 and caspase-3
proteins suggests that the mitochondrial pathway is in-
volved in apoptosis. Besides, we used various caspase in-
hibitors to further confirm our finding. As showed in
Fig. 3b, the specific caspase 8 inhibitor, Z-IETD was insuf-
ficient to increase cell viability, thereby excluding the pos-
sibility of involvement of the extrinsic pathway in CS-
induced apoptosis. However, ZDEVD (caspase-3 inhibitor)
and Z-LEHD (caspase-9 inhibitor) were sufficient at main-
taining cell viability, implying that the mitochondria-
mediated apoptotic pathway was the mechanism through
which CS induced cell death.
CS caused loss of mitochondrial membrane potential and
cytochrome C release
To confirm whether the mitochondria-mediated apop-
totic pathway was involved in the process of apoptosis,
the mitochondrial membrane potential (Δψm) in CS-
treated A549 and CL1-5 cells was measured. Loss of
mitochondrial membrane potential is an indicator of
mitochondrial damage during the process of apoptosis.
We used the fluorescent cationic dye JC-1 to evaluate
the effect of CS on membrane potential. A dose-
dependent decrease was observed in red fluorescence in
both cell lines, suggesting that CS treatment led to a
reduction in Δψm (Fig. 4a). A loss of Δψm can lead to
Fig. 2 Effects of CS on cell-cycle distribution and apoptosis in A549 and CL1-5 cells. a Cell-cycle analysis of CS-treated cells. Cells were treated
with the indicated concentrations of CS for 24 h and then subjected to cell cycle analysis. b Flow cytometry analysis of CS-induced apoptosis in
A549 and CL1-5 cells. The cells were treated with the indicated concentrations of CS for 24 h and then subjected to Annexin V/PI staining. The
means ± SD of the experimental triplicates are presented in the bar graph. All data are representative of three independent experiments with
similar results. *P value <0.05, **P value <0.01, ***P value <0.001 compared with the control group
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cytochrome c release from the mitochondria into the
cytosol, an important event for apoptosis induction [12].
Thus, the cytosolic fractions of A549 and CL1-5 cells
treated with 125 and 250 ng/ml of CS were prepared
and analyzed for cytochrome c release by Western
blotting. As presented in Fig. 5a, the expression of cyto-
chrome c in the cytosolic fractions was observed in both
A549 and CL1-5 cells treated with CS. Taken together,
our findings show that CS induces cell death via the
mitochondrial-mediated pathway.
CS reduced Bcl-2, Bcl-xl and IAPs protein expression in
A549 and CL1-5 cells
Bcl-2 family members are regulators of cytochrome c
release from mitochondria during the process of apoptosis
[13]. We assessed the protein expression of Bax, a proa-
poptotic member of the Bcl-2 family that triggers cyto-
chrome c release, and Bcl-2, an antiapoptotic member of
the family that inhibits cytochrome c release. As shown in
Fig. 5b, CS treatment for 24 h resulted in decreased the
levels of Bcl-2 protein and increased the expression of Bax
protein. In addition to the Bcl-2 family, the IAP family of
proteins also regulates caspase activity, thus affecting
apoptosis [14]. Therefore, we measured the expression of
two IAP family proteins, namely survivin and XIAP. As
demonstrated in Fig. 5b, the levels of XIAP and survivin
protein were markedly reduced after CS treatment, par-
ticularly in the A549 and CL1-5 cell lines.
CS inhibits CL1-5 tumor growth in a subcutaneous
xenograft tumor model
The prominent inhibitory effect of CS on NSCLC cell
proliferation in vitro suggested that CS might suppress
tumor growth in vivo. To verify this hypothesis, female
BALB/c nu/nu mice were subcutaneously inoculated
with CL1-5 cells and then fed orally with CS starting on
day 10 after tumor inoculation. As shown in Fig. 6a, CS
at 50 mg/kg resulted in a marked reduction in tumor
volume. Representative images of mice containing CL1-5
xenografts on day 21 are presented in Fig. 6b. These re-
sults indicate that CS also inhibits the growth of NSCLC
cells in vivo.
Fig. 3 Effects of CS on caspase activation in A549 and CL1-5 cells. a Cells were treated with the indicated concentrations of CS for 24 h. Total cell
proteins were extracted and immunoblotted with antibodies to detect the cleaved forms of caspase-8, caspase-9, caspase-3, and PARP. b Cells
were treated with CS (250 ng/ml) and/or the indicated caspase inhibitor for 24 h, and then cell viability was analyzed by the MTT assay. The
means ± SD of the experimental triplicates are presented in the bar graph. All data are representative of three independent experiments with
similar results. **P value <0.01, ***P value <0.001 compared with the control group
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Discussion
Several species of Chlorella have been reported to
have anti-cancer effects in various cancer cell lines.
The most commonly studied Chlorella species are
Chlorella vulgaris and Chlorella ellipsoidea. C. vulgaris
has been shown to have anti-cancer effects by indu-
cing apoptosis signaling cascades in the hepatoma cell
line HepG2 [15] and in rat models of liver cancer
[16]. A study comparing the anti-proliferative effects
of C. ellipsoidea with those of C. vulgaris in human
colon cancer cells revealed that the apoptosis-inducing
effect of C. ellipsoidea extract was almost 2.5 times
stronger than that of C. vulgaris extract [10]. However, to
the best of our knowledge, no studies have explored the
anti-cancer effects of C. sorokiniana (CS). The chemical
constituents of CS contain three liposoluble fractions and
five compounds namely, (22E, 24R)-5alpha, 3beta-
epidioxiergosta-6, 22-dien-3beta-ol, (24S)-ergosta-7-en-
3beta-ol, loliolide, stigmasta-7, 22-dien-3beta, 5alpha,
6alpha-triol, and 3beta-hydroxy-5alpha,6alpha-epoxy-7-
megastigmen-9-one [17]. In our study we found that CS
treatment resulted in an increase in the Bax/Bcl-2 ratio
and a decrease in expression of IAP family proteins XIAP
and survivin in human NSCLC cells. We also found that
oral feeding of CS resulted in a marked reduction in
tumor volume in a xenograft tumor model in mice. Our
results, therefore, demonstrate that CS induces apoptosis
in vitro and in vivo.
The anti-cancer effects of some natural compounds
have been shown to be the result of their ability to
modulate apoptosis signaling pathways [18]. In this
study, flow cytometric analysis of PI-labeled cells
Fig. 4 Effects of CS on mitochondrial membrane potential in A549 and CL1-5 cells. a and b Cells were treated with the indicated concentrations
of CS for 24 h and then subjected to JC-1 fluorescence dye staining. The change in mitochondrial membrane potential (ΔΨm) was examined by
flow cytometry. c The means ± SD of the experimental triplicates are presented in the bar graph. Data are representative of three independent experi-
ments with similar results. *P value <0.05, ***P value <0.001 compared with the control group
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revealed that exposure to CS resulted in a significant
increase in percentage of cells showing elevated hypo-
diploid DNA content (sub-G1) (Fig. 2a), indicating that
CS induces apoptosis in A549 and CL1-5 cells.
Cells undergo cell death through two major signaling
pathways, namely the mitochondria-dependent pathway
(intrinsic pathway) or the cell surface death receptor
signaling pathway (extrinsic pathway) [19]. Caspases play
important roles in the regulation of cell death and
inflammation [20]. In our study, the presence of early
apoptotic cells (annexin V+/PI−) (Fig. 2b), activated
forms of caspase-9 and caspase-3, and PARP cleavage
indicated that apoptosis (Fig. 3a), rather than necrosis,
was involved in CS-induced A549 and CL1-5 cell death.
Bcl-2 family proteins are involved in mitochondrial
dysfunction and participate in the mechanism of chemo-
therapy resistance [21]. The loss of mitochondrial
membrane potential is associated with apoptosis via
regulation of Bcl-2 family members. The Bcl-2 family
comprises anti-apoptotic proteins such as Bcl-2, XIAP,
and survivin, and pro-apoptotic proteins such as Bad,
Bax, and Bid [13]. Moreover, IAPs (inhibitors of apop-
tosis) can inhibit apoptosis by directly binding to acti-
vated effector caspases, such as caspase-3 and caspase-7,
and also inhibit mitochondrial cytochrome c-induced
caspase-9 activation [14, 22]. Cytochrome c release from
mitochondria into the cytosol acts as a caspase activator
and participates in the mitochondrial apoptotic pathway
[23]. In this study we identified apoptotic cells by
measuring cytochrome c release using a cytometric
technique with fluorescence microscopy. The release
of this mitochondrial component was labeled by the
staining pattern (Fig. 5a). Our results proved that CS
induces mitochondrial-mediated apoptosis in human
NSCLC cells.
Conclusions
In conclusion, we demonstrated that caspase-dependent
mitochondrial dysfunction is the mechanism through
which CS induces apoptosis in NSCLC cells. Downregu-
lation of Bcl-2, XIAP and survivin suggests that CS in-
creases the susceptibility of NSCLC cells to apoptosis
induction. In addition, our data show that the growth of
subcutaneous xenograft tumors was markedly inhibited
by oral administration of CS.
Fig. 5 Effects of CS on the expression of cytosolic cytochrome C,
Bcl-2 family and IAP proteins in A549 and CL1-5 cells. Cells were
treated with the indicated concentrations of CS for 24 h. a Cytosolic
fractions were extracted and subjected to immunoblotting with
anti-cytochrome c antibody. b Total cell proteins were extracted and
immunoblotted with antibodies to detect Bcl-2, Bax, XIAP, and
survivin. All data are representative of three independent experiments
with similar results
Fig. 6 Effects of CS on CL1-5 xenograft tumor growth in vivo.
a Mean tumor volume was measured at the indicated days after
tumor implant. b Representative images of mice containing CL1-5
xenografts on day 21. Experiments were repeated two times and
provided similar results
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